{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:18:45Z","timestamp":1778779125873,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.oret.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T03:24:34Z","timestamp":1641612274000},"page":"411-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin Inhibition"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-6026","authenticated-orcid":false,"given":"Frances","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"McGarrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennedy R.","family":"Geenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison H.","family":"Skalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian H.","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankoor S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efren","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-9394","authenticated-orcid":false,"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.01.003_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archderm.1994.01690030080013","article-title":"Tuberous sclerosis","volume":"130","author":"Kwiatkowski","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oret.2022.01.003_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation","volume":"14","author":"Roach","year":"1999","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archopht.1976.03910040149003","article-title":"Retinal lesions in tuberous sclerosis","volume":"94","author":"Nyboer","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib8","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ophtha.2012.03.020","article-title":"Tuberous sclerosis complex: genotype\/phenotype correlation of retinal findings","volume":"119","author":"Aronow","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.01.003_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/13816810.2020.1755989","article-title":"Juvenile cataract in association with tuberous sclerosis complex","volume":"41","author":"Geffrey","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2022.01.003_bib10","first-page":"5176","article-title":"Ophthalmic and genetic findings in a large cohort of patients with tuberous sclerosis complex","volume":"61","author":"McGarrey","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2022.01.003_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0420.2006.00781.x","article-title":"Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature","volume":"85","author":"Mennel","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.oret.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1755-3768.2007.01151.x","article-title":"Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas","volume":"86","author":"Eskelin","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3928\/23258160-20121221-19","article-title":"Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis","volume":"44","author":"Lonngi","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archopht.124.4.597","article-title":"Photodynamic therapy for exudative hamartoma in tuberous sclerosis","volume":"124","author":"Mennel","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archophthalmol.2007.54","article-title":"Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy","volume":"126","author":"Shields","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib16","first-page":"715","article-title":"Aggressive retinal astrocytoma associated with tuberous sclerosis","volume":"6","author":"Tomida","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ICB.0000000000000169","article-title":"Total regression of acquired retinal astrocytoma using photodynamic therapy","volume":"10","author":"House","year":"2016","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2022.01.003_bib18","first-page":"139","article-title":"Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex","volume":"102","author":"Shields","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2022.01.003_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJMe0707153","article-title":"Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis","volume":"358","author":"Paul","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2022.01.003_bib21","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ajmg.a.37148","article-title":"Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC)","volume":"167","author":"Pollack","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.oret.2022.01.003_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00006982-199313020-00013","article-title":"Giant cell astrocytoma of the retina in tuberous sclerosis","volume":"13","author":"Margo","year":"1993","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.01.003_bib23","first-page":"328","article-title":"Everolimus to treat aggressive retinal astrocytic hamartoma in tuberous sclerosis complex","volume":"21","author":"Nallasamy","year":"2017","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.oret.2022.01.003_bib24","first-page":"76","article-title":"Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus","volume":"22","author":"Zipori","year":"2018","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.oret.2022.01.003_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.oret.2017.08.005","article-title":"Everolimus for retinal astrocytic hamartomas in tuberous sclerosis complex","volume":"2","author":"Marciano","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.01.003_bib26","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ophtha.2015.03.023","article-title":"Sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex","volume":"122","author":"Zhang","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.01.003_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(14)71174-2","article-title":"Long-term observation of retinal lesions in tuberous sclerosis","volume":"119","author":"Zimmer-Galler","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0974-9233.106400","article-title":"Transient increased exudation after photodynamic therapy of intraocular tumors","volume":"20","author":"Mashayekhi","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1755-3768.2008.01331.x","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema","volume":"88","author":"Saito","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2022.01.003_bib30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.oret.2022.01.003_bib31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2022.01.003_bib32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2022.01.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1012-x","article-title":"Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis","volume":"14","author":"Li","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.oret.2022.01.003_bib34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","article-title":"Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): multicentre clinical experience","volume":"22","author":"Krueger","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.oret.2022.01.003_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3928\/23258160-20191031-10","article-title":"Spontaneous resolution of subretinal fluid secondary to retinal astrocytic hamartoma in tuberous sclerosis: a case report","volume":"50","author":"Amphornphruet","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2022.01.003_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0002-9394(01)01429-5","article-title":"Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosis","volume":"133","author":"Kiratli","year":"2002","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T07:48:35Z","timestamp":1715154515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2468653022000100"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.01.003","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin Inhibition","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}